CSPIA
FLGT icon

Cary Street Partners Investment Advisory’s Fulgent Genetics FLGT Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-101
Closed -$2.7K – 1022
2023
Q3 		$2.7K Hold
101
– – ﹤0.01% 1611
2023
Q2 		$3.74K Buy
+101
New +$3.52K ﹤0.01% 1480
2020
Q4 		– Sell
-400
Closed -$16K – 525
2020
Q3 		$16K Buy
+400
New +$12.5K ﹤0.01% 688

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cary Street Partners Investment Advisory's FLGT Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Fulgent Genetics (FLGT) in Q4 2023, closing a stake of 101 shares — an estimated $2.7K sold.

Cary Street Partners Investment Advisory first reported a position in FLGT in Q3 2020 and held it in 3 quarters. The position peaked at $16K in Q3 2020. 196 funds tracked by Wall St. Rank hold FLGT as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Fulgent Genetics position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 101 Fulgent Genetics shares in Q4 2023, an estimated $2.7K.
  • Cary Street Partners Investment Advisory first reported a position in Fulgent Genetics in Q3 2020 and held it in 3 quarters.
  • Cary Street Partners Investment Advisory's Fulgent Genetics position peaked at $16K in Q3 2020.
  • 196 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.